Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis

Abstract Background Alzheimer’s disease (AD) pathology begins several years before the clinical onset. The long preclinical phase is composed of three stages according to the 2011National Institute on Aging and Alzheimer’s Association (NIA-AA) criteria, followed by mild cognitive impairment (MCI), a...

Full description

Bibliographic Details
Main Authors: Lucilla Parnetti, Elena Chipi, Nicola Salvadori, Katia D’Andrea, Paolo Eusebi
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Alzheimer’s Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13195-018-0459-7